- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07946250
A Clinical Trial to Evaluate the Effects of Broc Shot Capsules on Skin Appearance and Comfort in Adults With Reactive, Blemish-Prone, or Hormonally Affected Skin
This is a randomized, double-blind, placebo-controlled, fully decentralized (remote) clinical trial evaluating the effects of Broc Shot Capsules on skin appearance and comfort in adults with reactive, blemish-prone, or hormonally affected skin. Fifty participants aged 18-65 years will be randomly assigned in a 1:1 ratio to receive either Broc Shot Capsules (active) or matched placebo capsules for 8 weeks.
Participants will take 2 capsules once daily and complete self-reported questionnaires and standardized self-captured skin photographs at Baseline, Week 4, and Week 8 via a secure online study platform. Expert dermatologist grading of photographs will be conducted remotely at each timepoint. The study is designed to substantiate consumer product claims related to visible skin improvement and participant-reported skin comfort, and is not intended to evaluate treatment of any clinical dermatological disease.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
- Navn: Gracia Walker
- E-mail: gracia@brocshot.com
Studiesteder
-
-
Nevada
-
Las Vegas, Nevada, Forenede Stater, 89101
- Citruslabs
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Adults aged 18 to 65 years (inclusive) at the time of consent.
- Self-reported skin concerns matching at least one of the following descriptions: I have red, itchy skin patches
- I have dry, flaky/scaley skin patches
- my skin has blemishes such as pimples, discoloured papules (small, tender bumps that are pink/red/purple/or darker than your natural skin tone) or pustules (a distinct white or yellow pus-filled center surrounded by a red base).
- Generally healthy adults who are willing and able to follow the study protocol for the full 8-week duration, including taking 2 capsules of the study product once daily for 8 consecutive weeks without skipping days, answering questionnaires at Baseline, Week 4, and Week 8, and following the photograph submission protocol at Baseline, Week 4, and Week 8.
- Willing to avoid initiating any new topical or oral skincare products, prescription medications targeting skin, or other dietary supplements specifically marketed for skin benefit during the study period.
- Participants currently using such products who have been using them consistently for at least 3 months prior to enrollment and are willing to continue unchanged throughout the study are eligible.
- Willing to maintain their current diet, lifestyle, sleep pattern, sun exposure habits, and skincare routine for the duration of the trial.
- Resides within the United States.
- Access to a smartphone or computer with internet connection and the ability to use the Citruslabs digital study platform.
Exclusion Criteria:
- Known allergy, hypersensitivity, or intolerance to broccoli, horseradish, other cruciferous vegetables (Brassicaceae family), or any component of the study product or placebo capsule.
- Currently pregnant, breastfeeding, or planning to become pregnant during the study period.
- Currently taking prescription anticoagulant medications (e.g., warfarin, apixaban, rivaroxaban) due to the potential for product ingredients to interact with anticoagulant activity.
- History of a severe or unstable medical condition that, in the opinion of the study team, would prevent safe participation or adherence to the protocol, including active cancer treatment.
- Currently using any oral, topical, or biologic prescription medication specifically indicated for a diagnosed dermatological condition, unless the regimen has been stable for at least 3 months and no changes are planned during the study period.
- Planned dermatological procedures during the study period (e.g., chemical peels, laser treatments, microneedling, injectable cosmetic procedures) that could confound skin appearance assessments.
- Currently enrolled in another clinical or consumer research study, or plans to enroll in any such study during the 8-week study period.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Dobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Placebo komparator: Placebo komparator
|
Participants will take 2 capsules once daily, with their first meal of the day, avoiding administration with hot or acidic liquids. |
|
Eksperimentel: BrocShot Collagen
|
Participants will take 2 capsules once daily, with their first meal of the day, avoiding administration with hot or acidic liquids. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Clinician-Assessed Change in Overall Skin Appearance
Tidsramme: Baseline to Week 8
|
Change from Baseline in overall skin appearance graded by a qualified dermatologist reviewing participant-submitted digital photographs using a binary Yes/No improvement scale assessing overall skin health, pigmentation, dryness, brightness, scarring, blemishes, redness, and flaking |
Baseline to Week 8
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Participant-Reported Change in Skin Appearance
Tidsramme: Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported skin appearance assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
|
Participant-Reported Change in Skin Clarity
Tidsramme: Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported skin clarity assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
|
Participant-Reported Change in Skin Calmness
Tidsramme: Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported skin calmness assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
|
Participant-Reported Change in Visible Skin Concerns
Tidsramme: Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported visible skin concerns assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
|
Participant-Reported Change in Skin Texture
Tidsramme: Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported skin texture assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
|
Participant-Reported Change in Skin Luminosity
Tidsramme: Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported skin luminosity assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
|
Participant-Reported Change in Skin Age Appearance
Tidsramme: Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported skin age appearance assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
|
Participant-Reported Change in Itching and Irritation
Tidsramme: Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported itching and irritation assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
|
Participant-Reported Change in Skin Comfort
Tidsramme: Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported skin comfort assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
|
Participant-Reported Change in Skin Confidence
Tidsramme: Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported skin confidence assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- BROCS-84181
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .